B-cell lymphoma refractory Clinical Trials

Delta Trials catalogs 20 clinical trials for B-cell lymphoma refractory in its publicly accessible dataset. Within this set, 4 currently recruiting participants and 3 trials have reached completion. This research occurs across 51 participating sites around the world. An additional 13 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 4 trials were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.